Galapagos NV (GLPG)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

€23.50

Buy

€24.50

arrow-up€0.70 (+3.04%)

Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.
Prices updated at 14 May 2025, 16:36 CEST
| Prices minimum 15 mins delay
|
Prices in EUR
FTSE EuroFirst 300
arrow-down-0.26%
Amsterdam
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
€24.88 - €23.42
€31.08 - €20.00
-
1,515.63m
-
-
399,152
0.55
108,380.78
-0.31
65.90m
BE0003818359
-2.58
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.